FRCPath Haemostasis and Thrombosis Training and Update (Online) Non-credit

Maintenance of blood fluidity and patency of the vascular system is crucial for normal human physiology. The term ‘haemostasis’ refers to the normal response of the vessel to injury by forming a clot that serves to limit haemorrhage. Thrombosis is pathological clot formation that results when haemostasis is excessively activated in the absence of bleeding. Under normal physiological conditions there is a delicate equilibrium between the pathological states of hypercoagulability and hypocoagulability in the circulating blood. Both inherited and acquired disorders can result in either bleeding or thrombosis.

Thrombosis may occur in veins (venous thrombosis) or in arteries (arterial thrombosis). Venous thrombosis leads to congestion of the affected part of the body, while arterial thrombosis affects the blood supply and leads to damage of the tissue supplied by that artery (ischaemia and necrosis). Fragments of either an arterial or a venous thrombus can also break off as an embolus which can travel through the circulation and cause thromboembolism. Accurate clinical and laboratory diagnosis of these disorders is therefore not only critical for the prevention of significant morbidity and mortality but improves patient care and quality of life through prevention and treatment of future bleeding and thrombotic events.

Our understanding of these physiological and pathophysiological conditions has also improved significantly over recent years. This has not only resulted in improved diagnosis but in the evolution of state of the art modern laboratory testing and therapies for both bleeding and thrombotic disorders. As the subject is also rapidly and continually evolving, this course aims to continually give up to date training from established clinicians and scientists in the field.

Learning outcomes:

• Understand the physiology and pathophysiology of all aspects of Haemostasis and Thrombosis
• Understand the clinical and laboratory diagnosis of inherited and acquired disorders of Haemostasis and Thrombosis
• Understand state of the art laboratory testing for diagnosing and monitoring treatment of Bleeding or Thrombotic Disorders
• Understand state of the art treatment strategies for either Bleeding or Thrombotic Disorders.

Accreditation:

The course is not accredited.

Course results:

Certificate of completion.

Programme teaching

• Up-to-date physiology and pathophysiology of Haemostasis and Thrombosis
• Comprehensive training in basic and advanced clinical and laboratory practice in Haemostasis and Thrombosis
• Interactive state of the art Lectures from established clinicians and scientists in the field
• FRCPath focussed
• 2 live sessions on Case based data interpretation
• 2 live Q&A sessions

Programme team:

• David Gurney, University Hospitals Birmingham
• Claire Harrison, Guy's and St Thomas'
• Will Lester, University Hospitals Birmingham
• Gill Lowe, University Hospitals Birmingham
• Neil Morgan, University of Birmingham
• Jayashree Motwani, Birmingham Women's and Children's Hospital
• Susie Shapiro, Oxford University Hospitals
• Marie Scully

Dates of the course:

1^st August – 31^st October 2025

Course programme (to be confirmed):
Course content:
(Provisional)

• 17th September: Will Lester, Jayashree Motwani, and Claire Harrison: General Q&A.
• 22nd September: David Gurney and Neil Morgan: laboratory testing Q&A.
• 23rd September: Susie Shapiro: clinical cases.
• 24th September: Gill Lowe: H&T Q&A.
• 25th September: Marie Scully: TTP and MAHA.

Programme subject to change.

This course is aimed at SpRs preparing for the part 2 FRCPath examination but is also suitable for clinicians, scientists and biomedical scientists in academia, the NHS, pharmaceutical and diagnostic companies wishing to gain intensive training in Haemostasis and Thrombosis.

£400 per person

To register for the course, please visit our online shop.

To enquire about the course, please use our enquiry form.

See how the University of Birmingham uses your data, view the Event attendee privacy notice.